Stock Split History
ETFs Holding HEB »    HEB Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AIM ImmunoTech is a pharmaceutical company. Co. is engaged in the development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Co.'s primary products include: Alferon N Injection® and the experimental therapeutic Ampligen®. Alferon N Injection® is approved for a category of sexually transmitted disease infection, and Ampligen® represents an experimental RNA being developed for viral diseases and disorders of the immune system. Co.'s platform technology includes components for potential treatment of various severely debilitating and life threatening diseases. According to our HEB stock split history records, HEB has had 2 splits.
HEB stock split history picture
HEB (HEB) has 2 splits in our HEB stock split history database. The first split for HEB took place on August 29, 2016. This was a 1 for 12 reverse split, meaning for each 12 shares of HEB owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 83.3333333333333 share position following the split. HEB's second split took place on June 11, 2019. This was a 1 for 44 reverse split, meaning for each 44 shares of HEB owned pre-split, the shareholder now owned 1 share. For example, a 83.3333333333333 share position pre-split, became a 1.89393939393939 share position following the split.

When a company such as HEB conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the HEB stock split history from start to finish, an original position size of 1000 shares would have turned into 1.89393939393939 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into HEB shares, starting with a $10,000 purchase of HEB, presented on a split-history-adjusted basis factoring in the complete HEB stock split history. HEB split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/23/2009
End date: 08/30/2019
Start price/share: $902.88
End price/share: $1.80
Dividends collected/share: $0.00
Total return: -99.80%
Average Annual Total Return: -46.78%
Starting investment: $10,000.00
Ending investment: $19.94
Years: 9.86
Date Ratio
08/29/20161 for 12
06/11/20191 for 44
HEB is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

HH Split History
HITK Split History
HMA Split History
HMSY Split History
HNSN Split History
HOLX Split History
HRC Split History
HSIC Split History
HSP Split History
HTBX Split History

Aethlon Medical, Inc. (AEMD)
Aberdeen Standard Physical Gold Shares ETF (SGOL)
Safe-T Group Ltd. (SFET)
NanoViricides, Inc. (NNVC)
Penns Woods Bancorp, Inc. (PWOD)
MoSys, Inc. (MOSY)
TOP Ships Inc. (TOPS)
Interlapse Technologies Corp. (INLA.CA)
SINTX Technologies, Inc. (SINT)
Pluristem Therapeutics Inc. (PSTI)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding HEB

HEB Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.